117 related articles for article (PubMed ID: 36395486)
1. Midterm outcomes of endovascular treatment for infected aortic aneurysms: Single center experience.
Suwanruangsri V; Bokerd S; Chinchalongporn W; Chanchitsopon V; Inlao P; Kaviros P
Vascular; 2024 Apr; 32(2):303-309. PubMed ID: 36395486
[TBL] [Abstract][Full Text] [Related]
2. Methicillin-resistant Staphylococcus aureus portends a poor prognosis after endovascular repair of mycotic aortic aneurysms and aortic graft infections.
Plotkin A; Magee GA; Elsayed RS; Byerly S; Ham SW; Han SM; Manzur MF; Rowe VL; Weaver FA
J Vasc Surg; 2020 Jul; 72(1):276-285. PubMed ID: 31843303
[TBL] [Abstract][Full Text] [Related]
3. Open versus endovascular repair of primary infected thoracic and abdominal aortic aneurysms.
Kritayakirana K; Narueponjirakul N; Aimsupanimitr P; Chaichote C; Uthaipaisanwong A; Kittayarak C
Vascular; 2024 Apr; 32(2):262-266. PubMed ID: 36395473
[TBL] [Abstract][Full Text] [Related]
4. Endovascular repair of acute juxtarenal and thoracoabdominal aortic aneurysms with surgeon-modified fenestrated endografts.
Juszczak MT; Vezzosi M; Khan M; Mascaro J; Claridge M; Adam D
J Vasc Surg; 2020 Aug; 72(2):435-444. PubMed ID: 31882311
[TBL] [Abstract][Full Text] [Related]
5. Open surgery and endovascular repair for mycotic aortic aneurysms: Benefits beyond survival.
Liu MY; Jiao Y; Yang Y; Li Q; Zhang X; Li W; Zhang X
J Thorac Cardiovasc Surg; 2020 May; 159(5):1708-1717.e3. PubMed ID: 30955965
[TBL] [Abstract][Full Text] [Related]
6. Fifteen-year, single-center experience with in situ reconstruction for infected native aortic aneurysms.
Berard X; Battut AS; Puges M; Carrer M; Stenson K; Cazanave C; Stecken L; Caradu C; Ducasse E
J Vasc Surg; 2022 Mar; 75(3):950-961.e5. PubMed ID: 34600030
[TBL] [Abstract][Full Text] [Related]
7. Chimney Endovascular Repair of Primary Mycotic Aneurysms Involving the Paravisceral Aorta.
Silverberg D; Abu Rmeileh A; Rimon U; Raskin D; Halak M
Ann Vasc Surg; 2020 Aug; 67():59-66. PubMed ID: 32209403
[TBL] [Abstract][Full Text] [Related]
8. Infection-relapse and a potentially surgical stratification model for the treatment of mycotic aortic aneurysms: A propensity-matched pilot study.
Liu M; Liu P; Liu B; Che H; Liu J; Sun A; Li W; Zhang X;
Vascular; 2019 Oct; 27(5):500-510. PubMed ID: 31017558
[No Abstract] [Full Text] [Related]
9. Prognostic factors after open and endovascular repair for infected native aneurysms of the abdominal aorta and common iliac artery.
Hosaka A; Takahashi A; Kumamaru H; Azuma N; Obara H; Miyata T; Obitsu Y; Zempo N; Miyata H; Komori K;
J Vasc Surg; 2024 Jun; 79(6):1379-1389. PubMed ID: 38280686
[TBL] [Abstract][Full Text] [Related]
10. Hybrid Treatment: Expanding the Armamentarium for Infected Infrarenal Abdominal Aortic and Iliac Aneurysms.
Han K; Lee DY; Kim MD; Lee S; Won JY; Kwon JH; Choi D; Ko YG
J Vasc Interv Radiol; 2017 Apr; 28(4):564-569. PubMed ID: 28034703
[TBL] [Abstract][Full Text] [Related]
11. The changing management of primary mycotic aortic aneurysms.
Vallejo N; Picardo NE; Bourke P; Bicknell C; Cheshire NJ; Jenkins MP; Wolfe J; Gibbs RG
J Vasc Surg; 2011 Aug; 54(2):334-40. PubMed ID: 21458201
[TBL] [Abstract][Full Text] [Related]
12. Role of Endovascular Aortic Repair in the Treatment of Infected Aortic Aneurysms Complicated by Aortoenteric or Aortobronchial Fistulae.
Kan CD; Lee HL; Yang YJ
Thorac Cardiovasc Surg; 2018 Apr; 66(3):240-247. PubMed ID: 29207434
[TBL] [Abstract][Full Text] [Related]
13. The management of endograft infections following endovascular thoracic and abdominal aneurysm repair.
Murphy EH; Szeto WY; Herdrich BJ; Jackson BM; Wang GJ; Bavaria JE; Fairman RM; Woo EY
J Vasc Surg; 2013 Nov; 58(5):1179-85. PubMed ID: 23830947
[TBL] [Abstract][Full Text] [Related]
14. Complementary Role of Fenestrated/Branched Endografting and the Chimney Technique in the Treatment of Pararenal Aneurysms After Open Abdominal Aortic Repair.
Reyes A; Donas KP; Pitoulias G; Austermann M; Gandarias C; Torsello G
J Endovasc Ther; 2016 Aug; 23(4):599-605. PubMed ID: 27170147
[TBL] [Abstract][Full Text] [Related]
15. Endovascular management of mycotic aortic aneurysms.
Silverberg D; Halak M; Yakubovitch D; Reinitz ER; Garniek A; Rimon U; Schneiderman J
Vasc Endovascular Surg; 2010 Nov; 44(8):693-6. PubMed ID: 20675323
[TBL] [Abstract][Full Text] [Related]
16. Endovascular therapy for infected aortic aneurysms.
Kritpracha B; Premprabha D; Sungsiri J; Tantarattanapong W; Rookkapan S; Juntarapatin P
J Vasc Surg; 2011 Nov; 54(5):1259-65; discussion 1265. PubMed ID: 21802238
[TBL] [Abstract][Full Text] [Related]
17. Treatment strategies and outcomes in patients with infected aortic endografts.
Fatima J; Duncan AA; de Grandis E; Oderich GS; Kalra M; Gloviczki P; Bower TC
J Vasc Surg; 2013 Aug; 58(2):371-9. PubMed ID: 23756338
[TBL] [Abstract][Full Text] [Related]
18. Midterm results from a physician-sponsored investigational device exemption clinical trial evaluating physician-modified endovascular grafts for the treatment of juxtarenal aortic aneurysms.
Starnes BW; Heneghan RE; Tatum B
J Vasc Surg; 2017 Feb; 65(2):294-302. PubMed ID: 27687323
[TBL] [Abstract][Full Text] [Related]
19. Two-year evaluation of fenestrated and parallel branch endografts for the treatment of juxtarenal, suprarenal, and thoracoabdominal aneurysms at a single institution.
Bannazadeh M; Beckerman WE; Korayem AH; McKinsey JF
J Vasc Surg; 2020 Jan; 71(1):15-22. PubMed ID: 31718954
[TBL] [Abstract][Full Text] [Related]
20. Early and midterm outcome of Multilayer Flow Modulator stent for complex aortic aneurysm treatment in Germany.
Ibrahim W; Spanos K; Gussmann A; Nienaber CA; Tessarek J; Walter H; Thalwitzer J; Debus SE; Tsilimparis N; Kölbel T
J Vasc Surg; 2018 Oct; 68(4):956-964. PubMed ID: 29602471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
